Correlation Between Rayliant Quantamental and ABIVAX Société
Can any of the company-specific risk be diversified away by investing in both Rayliant Quantamental and ABIVAX Société at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rayliant Quantamental and ABIVAX Société into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rayliant Quantamental Emerging and ABIVAX Socit Anonyme, you can compare the effects of market volatilities on Rayliant Quantamental and ABIVAX Société and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rayliant Quantamental with a short position of ABIVAX Société. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rayliant Quantamental and ABIVAX Société.
Diversification Opportunities for Rayliant Quantamental and ABIVAX Société
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Rayliant and ABIVAX is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Rayliant Quantamental Emerging and ABIVAX Socit Anonyme in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABIVAX Socit Anonyme and Rayliant Quantamental is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rayliant Quantamental Emerging are associated (or correlated) with ABIVAX Société. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABIVAX Socit Anonyme has no effect on the direction of Rayliant Quantamental i.e., Rayliant Quantamental and ABIVAX Société go up and down completely randomly.
Pair Corralation between Rayliant Quantamental and ABIVAX Société
Given the investment horizon of 90 days Rayliant Quantamental is expected to generate 3.37 times less return on investment than ABIVAX Société. But when comparing it to its historical volatility, Rayliant Quantamental Emerging is 6.23 times less risky than ABIVAX Société. It trades about 0.06 of its potential returns per unit of risk. ABIVAX Socit Anonyme is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 790.00 in ABIVAX Socit Anonyme on August 30, 2024 and sell it today you would earn a total of 315.00 from holding ABIVAX Socit Anonyme or generate 39.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Rayliant Quantamental Emerging vs. ABIVAX Socit Anonyme
Performance |
Timeline |
Rayliant Quantamental |
ABIVAX Socit Anonyme |
Rayliant Quantamental and ABIVAX Société Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Rayliant Quantamental and ABIVAX Société
The main advantage of trading using opposite Rayliant Quantamental and ABIVAX Société positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rayliant Quantamental position performs unexpectedly, ABIVAX Société can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABIVAX Société will offset losses from the drop in ABIVAX Société's long position.Rayliant Quantamental vs. ABIVAX Socit Anonyme | Rayliant Quantamental vs. HUMANA INC | Rayliant Quantamental vs. SCOR PK | Rayliant Quantamental vs. Aquagold International |
ABIVAX Société vs. Advanced Proteome Therapeutics | ABIVAX Société vs. ChitogenX | ABIVAX Société vs. Northwest Biotherapeutics | ABIVAX Société vs. Geron |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |